Sultan A. Baig
Fortune : 300 214 $ au 31/05/2026
Fortune : 300 214 $ au 31/05/2026
Sultan A. Baig currently works at The Institute of Chartered Accountants of India, as Member.
Mr. Baig also formerly worked at Biological E.
Ltd., as Vice President-Finance and Nava Ltd., as Chief Financial Officer from 2020 to 2025.
Mr. Baig received his undergraduate degree from the University of Pune.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
NAVA LIMITED 0,02 % | 21/11/2024 | 48 018 ( 0,02 % ) | 300 214 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
The Institute of Chartered Accountants of India
The Institute of Chartered Accountants of India Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
| Sociétés | Poste | Fin |
|---|---|---|
| NAVA LIMITED | Directeur Financier/CFO | 07/02/2025 |
Biological E. Ltd.
Biological E. Ltd. Pharmaceuticals: MajorHealth Technology Manufactures liver extracts and anti-coagulants for treating diseases | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
Nava Ltd.
Nava Ltd. Electric UtilitiesUtilities Manufactures ferro alloys, sugar, mining and power generation | Utilities |
University of Pune
University of Pune Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Institute of Chartered Accountants of India
The Institute of Chartered Accountants of India Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biological E. Ltd.
Biological E. Ltd. Pharmaceuticals: MajorHealth Technology Manufactures liver extracts and anti-coagulants for treating diseases | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national